Additionally, CSF PCSK9 was positively correlated with AD biomarkers including Aβ1–42, P-tau, and T-tau independent of AD (Cariou et al., 2017; Courtemanche et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.